Search - tctmd.com

Displaying 1 - 20 of 50

Sort: Relevancy | Date

Extreme Alcohol Intake Directly Damages the Heart, Study Confirms

News Daily News

Extreme Alcohol Intake Directly Damages the Heart, Study Confirms

December 24, 2019

Year in Review: New Guidelines, Inclisiran, Dapagliflozin Impact CVD Prevention in 2019

News Daily News

Year in Review: New Guidelines, Inclisiran, Dapagliflozin Impact CVD Prevention in 2019

Yael L. Maxwell

December 20, 2019

Year in Review: ISCHEMIA Tops Coronary News in 2019 but Other Trials Shine, Too

News Features

Year in Review: ISCHEMIA Tops Coronary News in 2019 but Other Trials Shine, Too

Michael O'Riordan

December 09, 2019

Off Script: After ISCHEMIA, the Devil Is in the (Design) Details

News Opinion Off Script

Off Script: After ISCHEMIA, the Devil Is in the (Design) Details

Ajay Kirtane, MD, SM

November 28, 2019

Some A-fib Patients May Need a Bit More Aspirin After PCI: AUGUSTUS

News Conference News AHA 2019

Some A-fib Patients May Need a Bit More Aspirin After PCI: AUGUSTUS

November 20, 2019

Solid 2-Year Outcomes for Portico, With Paravalvular Leak Rare

News Conference News PCR London Valves 2019

Solid 2-Year Outcomes for Portico, With Paravalvular Leak Rare

Michael O'Riordan

November 20, 2019

ISCHEMIA: Invasive Strategy No Better Than Meds for CV Events

News Conference News AHA 2019

ISCHEMIA: Invasive Strategy No Better Than Meds for CV Events

November 16, 2019

ISCHEMIA-CKD: Routine Invasive Approach No Help in CKD Patients With Stable CAD

News Conference News AHA 2019

ISCHEMIA-CKD: Routine Invasive Approach No Help in CKD Patients With Stable CAD

November 16, 2019

COLCOT Renews Hope for Anti-inflammatory Secondary Prevention

News Conference News AHA 2019

COLCOT Renews Hope for Anti-inflammatory in Secondary Prevention: Colchicine

November 16, 2019

Cardioversion Without Anticoagulation Appears Safe in Patients With Watchman

News Daily News

Cardioversion Without Anticoagulation Appears Safe in Patients With Watchman

November 01, 2019

Chronic Stress in African-Americans Linked to Hypertension

News

Chronic Stress in African-Americans Linked to Hypertension

October 16, 2019

FDA Gives Rivaroxaban Another VTE-Related Indication

News Daily News

FDA Gives Rivaroxaban Another VTE-Related Indication

October 14, 2019

Transcatheter Options Best for Tricuspid Regurgitation in Matched Registry Analysis

News Conference News TCT 2019

Transcatheter Options Best for Tricuspid Regurgitation in Matched Registry Analysis

Michael O'Riordan

September 27, 2019

High-Sensitivity Troponin T May Offer Glimpse Into Future HF Risk: ARIC Analysis

News Daily News

High-Sensitivity Troponin T May Offer Glimpse Into Future HF Risk: ARIC Analysis

September 13, 2019

Community-Level Salt-Swapping Strategy Pays Dividends in Peru

News Conference News ESC 2019

Community-Level Salt-Swapping Strategy Pays Dividends in Peru

September 09, 2019

AFIRE Supports Rivaroxaban Monotherapy in A-fib Patients With Stable CAD

News Conference News ESC 2019

AFIRE Supports Rivaroxaban Monotherapy in A-fib Patients With Stable CAD

September 02, 2019

COMPLETE Beats Culprit-Only PCI in Multivessel STEMI and Timing Doesn’t Matter

News Conference News ESC 2019

COMPLETE Beats Culprit-Only PCI in Multivessel STEMI and Timing Doesn’t Matter

Yael L. Maxwell

September 01, 2019

Safe to Leave Recalled Sprint Fidelis ICD Leads in Place? Debate Continues

News Daily News

Safe to Leave Recalled Sprint Fidelis ICD Leads in Place? Debate Continues

August 28, 2019

Use of IVC Filters for DVT Peaked in 2010 but Remains High

News Daily News

Use of IVC Filters for DVT Peaked in 2010 but Remains High

Michael O'Riordan

August 28, 2019

Learning Curve for New CTO Operators: Some Reassurances, Some Caveats

News Daily News

Learning Curve for New CTO Operators: Some Reassurances, Some Caveats

August 26, 2019

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.